Value Bridge — BAPTIST HEALTH LEXINGTON
Current $21M → Target $38M (+$16.8M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$21.1M
Current EBITDA
$38.0M
Target EBITDA
+$16.8M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.8M
Payer Mix Optimization
$9.1M
Cost to Collect Reduction
$3.0M
Clean Claim Improvement
$2.3M
Volume & Rate Growth
$15.2M
What This Means
The 7-lever model projects a 79% EBITDA uplift from $21M to $38M. The highest-impact lever is Volume & Rate Growth at $6.1M probability-weighted.
IC talking point: "We see $17M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $185M in equity value creation."